Identification of a CDH12 potential candidate genetic variant for an autosomal dominant form of transgrediens and progrediens palmoplantar keratoderma in a Tunisian family.


Journal

Journal of human genetics
ISSN: 1435-232X
Titre abrégé: J Hum Genet
Pays: England
ID NLM: 9808008

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 22 03 2019
accepted: 01 12 2019
revised: 29 11 2019
pubmed: 9 1 2020
medline: 9 10 2020
entrez: 9 1 2020
Statut: ppublish

Résumé

Molecular diagnosis of rare inherited palmoplantar keratoderma (PPK) is still challenging. We investigated at the clinical and genetic level a consanguineous Tunisian family presenting an autosomal dominant atypical form of transgrediens and progrediens PPK to better characterize this ultrarare disease and to identify its molecular etiology. Whole-exome sequencing (WES), filtering strategies, and bioinformatics analysis have been achieved. Clinical investigation and follow up over 13 years of this Tunisian family with three siblings formerly diagnosed as an autosomal recessive form of Mal de Melela-like conducted us to reconsider its initial phenotype. Indeed, the three patients presented clinical features that overlap both Mal de Meleda and progressive symmetric erythrokeratoderma (PSEK). The mode of inheritance was also reconsidered, since the mother, initially classified as unaffected, exhibited a similar expression of the disease. WES analysis showed the absence of potentially functional rare variants in known PPKs or PSEK-related genes. Results revealed a novel heterozygous nonsynonymous variant in cadherin-12 gene (CDH12, NM_004061, c.1655C > A, p.Thr552Asn) in all affected family members. This variant is absent in dbSNP and in 50 in-house control exomes. In addition, in silico analysis of the mutated 3D domain structure predicted that this variant would result in cadherin-12 protein destabilization and thermal instability. Functional annotation and biological network construction data provide further supporting evidence for the potential role of CDH12 in the maintenance of skin integrity. Taken together, these results suggest that CDH12 gene is a potential candidate gene for an atypical presentation of an autosomal dominant form of transgrediens and progrediens PPK.

Identifiants

pubmed: 31911611
doi: 10.1038/s10038-019-0711-4
pii: 10.1038/s10038-019-0711-4
doi:

Substances chimiques

CDH23 protein, human 0
Cadherin Related Proteins 0
Cadherins 0

Types de publication

Case Reports Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-410

Références

Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33:228–37. http://www.ncbi.nlm.nih.gov/pubmed/12610532 .
doi: 10.1038/ng1090
Lai-Cheong JE, McGrath JA. Next-generation diagnostics for inherited skin disorders. J Investig Dermatol. 2011;131:1971–3. https://linkinghub.elsevier.com/retrieve/pii/S0022202X15350557 .
doi: 10.1038/jid.2011.253
Hsu TM, Kwok PY. Advances in molecular medicine. J Am Acad Dermatol. 2001;44:847–55. http://linkinghub.elsevier.com/retrieve/pii/S0190962201537731 .
doi: 10.1067/mjd.2001.114293
Kimyai-Asadi A, Kotcher LB, Jih MH. The molecular basis of hereditary palmoplantar keratodermas. J Am Acad Dermatol. 2002;47:327–43. http://www.ncbi.nlm.nih.gov/pubmed/12196741 .
doi: 10.1067/mjd.2002.124814
Bchetnia M, Charfeddine C, Kassar S, Zribi H, Guettiti HT, Ellouze F, et al. Clinical and mutational heterogeneity of Darier disease in Tunisian Families. Arch Dermatol. 2009;145. https://doi.org/10.1001/archdermatol.2009.52 .
Bchetnia M, Laroussi N, Youssef M, Charfeddine C, Ben Brick AS, Boubaker MS, et al. Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region. Biomed Res Int. 2013;2013:1–7. http://www.hindawi.com/journals/bmri/2013/206803/ .
doi: 10.1155/2013/206803
Charfeddine C, Mokni M, Kassar S, Zribi H, Bouchlaka C, Boubaker S, et al. Further evidence of the clinical and genetic heterogeneity of recessive transgressive PPK in the Mediterranean region. J Hum Genet. 2006;51:841–5. https://doi.org/10.1007/s10038-006-0002-8 .
doi: 10.1007/s10038-006-0002-8 pubmed: 16865292
Castellana S, Mazza T. Congruency in the prediction of pathogenic missense mutations: state-of-the-art web-based tools. Brief Bioinform. 2013;14:448–59. http://www.ncbi.nlm.nih.gov/pubmed/23505257 .
doi: 10.1093/bib/bbt013
Castellana S, Fusilli C, Mazza T. A broad overview of computational methods for predicting the pathophysiological effects of non-synonymous variants. 2016; 423–40. http://link.springer.com/10.1007/978-1-4939-3572-7_22 .
Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67. https://doi.org/10.1093/nar/gkp215 .
doi: 10.1093/nar/gkp215
Has C, Technau-Hafsi K. Palmoplantar keratodermas: clinical and genetic aspects. J der Dtsch Dermatologischen Ges. 2016;14:123–40. http://www.ncbi.nlm.nih.gov/pubmed/26819106 .
Stelzer G, Plaschkes I, Oz-Levi D, Alkelai A, Olender T, Zimmerman S, et al. VarElect: the phenotype-based variation prioritizer of the GeneCards Suite. BMC Genom. 2016;17 Suppl 2:444. http://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-016-2722-2 .
doi: 10.1186/s12864-016-2722-2
Chivian D, Kim DE, Malmström L, Bradley P, Robertson T, Murphy P, et al. Automated prediction of CASP-5 structures using the Robetta server. Proteins. 2003;53 Suppl 6:524–33. https://doi.org/10.1002/prot.10529 .
doi: 10.1002/prot.10529
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–13.
doi: 10.1093/nar/gky1131
Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38 Suppl 2: (Web Server issue) W214–W220.
doi: 10.1093/nar/gkq537
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.
doi: 10.1101/gr.1239303
Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091–3. http://www.ncbi.nlm.nih.gov/pubmed/19237447 .
doi: 10.1093/bioinformatics/btp101
Bindea G, Galon J, Mlecnik B. CluePedia cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29:661–3. http://www.ncbi.nlm.nih.gov/pubmed/23325622 .
doi: 10.1093/bioinformatics/btt019
Shapiro L, Weis WI. Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol. 2009;1:a003053. https://doi.org/10.1101/cshperspect.a003053 .
doi: 10.1101/cshperspect.a003053
Zhao L, Vahlquist A, Virtanen M, Wennerstrand L, Lind L, Lundström A, et al. Palmoplantar keratoderma of the Gamborg-Nielsen type is caused by mutations in the SLURP1 gene and represents a variant of Mal de Meleda. Acta Derm Venereol. 2014;94:707–10. http://www.ncbi.nlm.nih.gov/pubmed/24604124 .
doi: 10.2340/00015555-1840
Kubo A. Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency. J Investig Dermatol. 2014;134:2076–9. https://linkinghub.elsevier.com/retrieve/pii/S0022202X15369499 .
doi: 10.1038/jid.2014.156
Athanikar SB, Inamadar AC, Palit A, Sampagavi VV, Deshmukh NS. Greither’s disease. Indian J Dermatol Venereol Leprol.2003;69:292–3.  http://www.ncbi.nlm.nih.gov/pubmed/17642916 .
Duchatelet S, Hovnanian A. Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia. J Investig Dermatol. 2015;135:1475–8. https://linkinghub.elsevier.com/retrieve/pii/S0022202X15372687 .
doi: 10.1038/jid.2014.535
Mahajan V, Khatri G, Chauhan P, Mehta K, Raina R, Gupta M. Progressive symmetric erythrokeratoderma having overlapping features with erythrokeratoderma variabilis and lesional hypertrichosis: is nomenclature “erythrokeratoderma variabilis progressiva” more appropriate? Indian J Dermatol. 2015;60:410 http://www.ncbi.nlm.nih.gov/pubmed/26288417 .
doi: 10.4103/0019-5154.160499
Prabhu S, Shenoi SD, Pai SB, Handattu S, Bhattachan B. Progressive and symmetric erythrokeratoderma of adult onset: a rare case. Indian Dermatol Online J. 2010;1:43–5. http://www.idoj.in/text.asp?2010/1/1/43/73261 .
doi: 10.4103/2229-5178.73261
Wei S, Zhou Y, Zhang TD, Huang ZM, Zhang XB, Zhu HL, et al. Evidence for the absence of mutations at GJB3, GJB4 and LOR in progressive symmetrical erythrokeratodermia. Clin Exp Dermatol. 2011;36:399–405. https://doi.org/10.1111/j.1365-2230.2010.03974.x .
doi: 10.1111/j.1365-2230.2010.03974.x
Common JEA, O’Toole EA, Leigh IM, Thomas A, Griffiths WAD, Venning V, et al. Clinical and genetic heterogeneity of erythrokeratoderma variabilis. J Investig Dermatol. 2005;125:920–7. https://linkinghub.elsevier.com/retrieve/pii/S0022202X15325069 .
doi: 10.1111/j.0022-202X.2005.23919.x
van Steensel MAM, Oranje AP, van der Schroeff JG, Wagner A, van Geel M. The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron. Am J Med Genet A. 2009;149A:657–61. https://doi.org/10.1002/ajmg.a.32744 .
doi: 10.1002/ajmg.a.32744
Ishida-Yamamoto A. Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin. J Dermatol Sci. 2003;31:3–8. http://www.ncbi.nlm.nih.gov/pubmed/12615358 .
doi: 10.1016/S0923-1811(02)00143-3
Bouadjar B, Benmazouzia S, Prud’homme JF, Cure S, Fischer J. Clinical and genetic studies of 3 large, consanguineous, Algerian families with Mal de Meleda. Arch Dermatol. 2000;136:1247–52. http://www.ncbi.nlm.nih.gov/pubmed/11030771 .
doi: 10.1001/archderm.136.10.1247
Schiller S, Seebode C, Hennies HC, Giehl K, Emmert S. Palmoplantar keratoderma (PPK): acquired and genetic causes of a not so rare disease. J Dtsch Dermatol Ges. 2014;12:781–8. https://doi.org/10.1111/ddg.12418 .
pubmed: 25176457
Sakiyama T, Kubo A. Hereditary palmoplantar keratoderma “clinical and genetic differential diagnosis.”. J Dermatol. 2016;43:264–74. http://www.ncbi.nlm.nih.gov/pubmed/26945534 .
doi: 10.1111/1346-8138.13219
Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH, et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet. 1998;20:366–9. http://www.nature.com/articles/ng1298_366 .
doi: 10.1038/3840
Macari F, Landau M, Cousin P, Mevorah B, Brenner S, Panizzon R, et al. Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Am J Hum Genet. 2000;67:1296–301. https://linkinghub.elsevier.com/retrieve/pii/S0002929707629577 .
doi: 10.1016/S0002-9297(07)62957-7
Boyden LM, Craiglow BG, Zhou J, Hu R, Loring EC, Morel KD, et al. Dominant de novo mutations in GJA1 cause erythrokeratodermia variabilis et progressiva, without features of oculodentodigital dysplasia. J Investig Dermatol. 2015;135:1540–7. https://linkinghub.elsevier.com/retrieve/pii/S0022202X15372833 .
doi: 10.1038/jid.2014.485
Kaliannan K, Hamarneh SR, Economopoulos KP, Nasrin Alam S, Moaven O, Patel P, et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci USA. 2013;110:7003–8. https://doi.org/10.1073/pnas.1220180110 .
doi: 10.1073/pnas.1220180110
Redies C, Hertel N, Hübner CA. Cadherins and neuropsychiatric disorders. Brain Res. 2012;1470:130–44. https://linkinghub.elsevier.com/retrieve/pii/S0006899312010736 .
doi: 10.1016/j.brainres.2012.06.020
Gloushankova NA. Changes in regulation of cell-cell adhesion during tumor transformation. Biochemistry. 2008;73:742–50. http://www.ncbi.nlm.nih.gov/pubmed/18707582 .
pubmed: 18707582
El-Amraoui A, Petit C. Cadherins as targets for genetic diseases. Cold Spring Harb Perspect Biol. 2010;2:a003095. https://doi.org/10.1101/cshperspect.a003095 .
doi: 10.1101/cshperspect.a003095
Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol. 2002;4:E101–8. http://www.nature.com/articles/ncb0402-e101 .
doi: 10.1038/ncb0402-e101
Fujimori T, Takeichi M. Disruption of epithelial cell-cell adhesion by exogenous expression of a mutated nonfunctional N-cadherin. Mol Biol Cell. 1993;4:37–47. http://www.ncbi.nlm.nih.gov/pubmed/8443408 .
doi: 10.1091/mbc.4.1.37
Pontén FK, Schwenk JM, Asplund A, Edqvist PHD. The Human Protein Atlas as a proteomic resource for biomarker discovery. J Intern Med. 2011;270:428–46.
doi: 10.1111/j.1365-2796.2011.02427.x
Yin L, Coelho SG, Ebsen D, Smuda C, Mahns A, Miller SA, et al. Epidermal gene expression and ethnic pigmentation variations among individuals of Asian, European and African ancestry. Exp Dermatol. 2014;23:731–5. https://doi.org/10.1111/exd.12518 .
doi: 10.1111/exd.12518
Del Bino S, Duval C, Bernerd F. Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact. Int J Mol Sci. 2018;19:2668. https://doi.org/10.3390/ijms19092668
doi: 10.3390/ijms19092668

Auteurs

Cherine Charfeddine (C)

Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia. cherine.charfeddine@gmail.com.
High Institute of Biotechnology of Sidi Thabet, Biotechpole of Sidi Thabet, University of Manouba, 2020, Ariana, Tunisia. cherine.charfeddine@gmail.com.

Hamza Dallali (H)

Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Ghaith Abdessalem (G)

Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Kais Ghedira (K)

Laboratory of Bioinformatics, Biomathematics and Biostatistics - LR16IPT09, Pasteur Institute of Tunis, University Tunis El Manar, Tunis, Tunisia.

Yosr Hamdi (Y)

Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Sahar Elouej (S)

Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Marseille Medical Genetics U 1251, Aix Marseille Université Faculté de Médecine de la Timone, Marseille, France.

Zied Landoulsi (Z)

Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Bioinformatics Core, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Sur-Alzette, Luxembourg.

Valérie Delague (V)

Marseille Medical Genetics U 1251, Aix Marseille Université Faculté de Médecine de la Timone, Marseille, France.

Arnaud Lagarde (A)

Marseille Medical Genetics U 1251, Aix Marseille Université Faculté de Médecine de la Timone, Marseille, France.

Nicolas Levy (N)

Marseille Medical Genetics U 1251, Aix Marseille Université Faculté de Médecine de la Timone, Marseille, France.

Aziz El-Amraoui (A)

Génétique et Physiologie de l'Audition, Institut Pasteur, INSERM UMRS1120, Sorbonne University, 75015, Paris, France.

Mohamed Samir Boubaker (MS)

Laboratory of Human and Experimental Pathology, Pasteur Institute of Tunis, Tunis, Tunisia.

Sonia Abdelhak (S)

Laboratory of Biomedical Genomics and Oncogenetics, LR16IPT05, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Mourad Mokni (M)

Department of Dermatology, CHU La Rabta Tunis, 1007, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH